Nijkamp and Parnham's Principles of Immunopharmacology

PART 1 - Immunity Initiation, Propagation and Resolution of Inflammation.- Haematopoeisis and lymphocyte development: an introduction.- T cell subsets and T-cell mediated immunity.- Antibody diversity and B-cell mediated immunity.- Dendritic cells.- Cytokines.- Epigenetic regulation of immunity.- Innate immunity: phagocytes, NK cells, and and humoral defence.- Inflammatory mediators and intracellular signalling.- Immune response in human pathology: infections caused by bacteria, viruses, fungi, and parasites.- Immune response in human pathology: hypersensitivity and autoimmunity.- Cancer immunity.- Neuroimmunoendocrinology. PART 2 - Immunodiagnosis Antibody detection.- Immunoassays.- Flow cytometry.- Microarrays.- Imaging Inflammation.- PART 3 - Immunotherapeutics.- Vaccines and adjuvants.- Plasma-derived immunoglobulins.- Monoclonal antibodies for the treatment of immune.- Anti-allergic drugs.- Drugs for the treatment of airway disease.- Immunotherapy in the management of asthma and other allergic conditions.- Immunostimulants  in cancer therapy.- Immunomodulation in sepsis and infection.- Immunopharmacology of probiotics and prebiotics.- Mild plant and dietary immunomodulators.- Influence of antibacterial drugs on the immune system.- Cytotoxic drugs.- Immunosuppressives in transplant rejection.- Corticosteroids.- Non-steroidal anti-inflammatory drugs.- Disease-modifying antirheumatic drugs.- Drugs for soft tissue autoimmune disorders.- Cell and gene therapy of immune disorders.- PART 4 - Immunotoxicology Immunotoxicology 2017.

Michael J Parnham is Head of Translational Validation in the Fraunhofer Institute for Molecular Biology & Applied Ecology IME Branch for Translational Medicine and Biology TMP and Professor of Pharmacology and Toxicology at Goethe University Frankfurt, Germany. He was Editor of the journal Inflammation Research for 30 years and is Chief Editor of Compendium of Inflammatory Diseases. He directs research on novel methods, biomarkers and drug candidates for pain, autoimmunity and inflammation, working closely with clinical colleagues and industry. After studies in pharmacology in London and Bristol and postdoc research at Erasmus University Rotterdam, he spent over 30 years in senior research management in drug discovery and preclinical development with Nattermann, Rhône-Poulenc, PLIVA and GSK, including an 8 year period as a consultant. He helped take 6 projects to clinical trials. He is a co-recipient of the Galenus-von Pergamon Prize Germany, recipient of the Lifetime Achievement Award of the International Association of Inflammation Societies and a Fellow of the British Pharmacological Society.

Frans P. Nijkamp, emeritus professor Pharmacology, Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. He was head of the Department of Pharmacology and Pathphysiology. He was Editor-in-Chief of the European Journal of Pharmacology. His main field of research was focussed around the Immunopharmacology of the Respiratory- and Gastrointestinal system. He was (co)author of more than 500 scientific publications. In 2006 he received the Saal van Zwanenburg Price for his total scientific oeuvre. Adriano G Rossi is Deputy Director and Postgraduate Director of the Centre for Inflammation Research at the University of Edinburgh. He obtained a BSc (Hons) degree in Pharmacology (1984) and a PhD degree (1987) from the Department of Pharmacology, University of Glasgow and carried out postdoctoral research at Wake